FDA Inspection 1302588 — Wyeth Pharmaceuticals Llc
The FDA completed an inspection of Wyeth Pharmaceuticals Llc on April 7, 2026 in Collegeville, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 7, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Collegeville, PA (United States)